Compare LTC Properties Inc (LTC) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LTC Properties Inc vs Mesoblast Limited — how do they compare? LTC Properties Inc trades at $38.12 (market cap $2.05B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: LTC Properties Inc and Mesoblast Limited are close in size by market cap, and LTC Properties Inc pays a 5.98% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| LTC | MESO | |
|---|---|---|
Market Cap | $2.05B | $2.21B |
Sector | Real Estate | Technology |
52-Week High | $42.81 | $20.96 |
52-Week Low | $33.98 | $12.88 |
Enterprise Value | $2.79B | $2.21B |
Dividend Yield | 5.98% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
